Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

SHA/603309 stock hub

SHA/603309 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/603309is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.1B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/603309

In the news

Latest news · SHA/603309

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.1

P25 17.1P50 24.2P75 37.8

Trailing P/E53.5

P25 23.5P50 41.3P75 83.2

ROE4.6

P25 -0.9P50 4.1P75 8.8

ROIC11

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/603309 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

CNY

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,622
Employees Change	96%
Employees Change Percent	3.8
Enterprise value	CNY 4.3B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	CNE1000021C2
Last refreshed	2026-05-10
Market cap	CNY 4.1B
Price	CNY 14.2
Price currency	CNY
Rev Per Employee	625,476.13x
Sector	Healthcare
Sic	3841
Symbol	sha/603309
Website	https://www.wellead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.87%
EV Earnings	55.05x
EV/EBIT	13.68x
EV/EBITDA	10.5x
EV/FCF	26.7x
EV/Sales	2.6x
FCF yield	3.85%
Forward P/E	13.15x
P/B ratio	2.25x
P/E ratio	53.47x
P/S ratio	2.53x
PE Ratio10 Y	34.71x
PE Ratio3 Y	24.17x
PE Ratio5 Y	28.2x
PEG ratio	0.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.98%
EBITDA Margin	24.21%
FCF margin	9.72%
Gross margin	45.1%
Gross Profit	CNY 739.6M
Gross Profit Growth	8.33%
Gross Profit Growth Q	6.33%
Gross Profit Growth3 Y	6.26%
Gross Profit Growth5 Y	7.25%
Net Income	CNY 77.3M
Net Income Growth	-66.08%
Net Income Growth Q	1.73%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-24.55%
Net Income Growth5 Y	-14.36%
Pretax Margin	8.03%
Profit Margin	4.72%
Profit Per Employee	CNY 29,500
Profitable Years	15
ROA	6.97
Roa5y	5.8
ROCE	13.67
ROE	4.65
Roe5y	9.49
ROIC	11.02
Roic5y	11.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.61%
Cagr1y	27.79%
Cagr3y	-4.67%
Cagr5y	3.92%
Div CAGR3	27.22%
Div CAGR5	28.47%
EPS Growth	-65.97
EPS Growth Q	5
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-24.63
EPS Growth5 Y	-16.49
FCF Growth3 Y	-10.79%
FCF Growth5 Y	8.05%
OCF Growth	35.6%
OCF Growth Q	355.34%
OCF Growth10 Y	17.25%
OCF Growth3 Y	-3.78%
OCF Growth5 Y	12.36%
Revenue Growth	5.92x
Revenue Growth Q	2.53x
Revenue Growth Quarters	1x
Revenue Growth Years	4x
Revenue Growth3 Y	4.82x
Revenue Growth5 Y	6.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.59
Assets	CNY 2.8B
Cash	CNY 460M
Current Assets	CNY 868.8M
Current Liabilities	CNY 474.7M
Debt	CNY 556.5M
Debt EBITDA	CNY 1.37
Debt Equity	CNY 0.3
Debt FCF	CNY 3.49
Equity	CNY 1.8B
Interest Coverage	277.5
Liabilities	CNY 911.8M
Long Term Assets	CNY 1.9B
Long Term Liabilities	CNY 437.1M
Net Cash	CNY -96.5M
Net Cash By Market Cap	CNY -2.33
Net Debt EBITDA	CNY 0.24
Net Debt Equity	CNY 0.05
Net Debt FCF	CNY 0.61
Tangible Book Value	CNY 1.5B
Tangible Book Value Per Share	CNY 5.29
WACC	2.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.83
Inventory Turnover	5
Net Working Capital	CNY 104.2M
Quick ratio	1.38
Working Capital	CNY 394.1M
Working Capital Turnover	CNY 3.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.4
Dividend Years	10
Dividend Yield	2.82%
Ex Div Date	2026-01-08
Last Dividend	CNY 0.2
Payout Frequency	Annual
Payout Ratio	280.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-23.26%
1Y total return	27.76%
200-day SMA	14.19
3Y total return	-13.36%
50-day SMA	14.56
50-day SMA vs 200-day SMA	50over200
5Y total return	21.19%
All Time High	39.42
All Time High Change	-63.98%
All Time High Date	2015-05-28
All Time Low	6.42
All Time Low Change	121.08%
All Time Low Date	2018-10-19
ATR	0.5
Beta	-0.17
Beta1y	0.4
Beta2y	0.57
Ch YTD	4.49
High	14.25
High52	16.42
High52 Date	2026-03-11
High52ch	-13.52%
Low	14.03
Low52	11.69
Low52 Date	2025-05-08
Low52ch	22.2%
Ma50ch	-2.46%
Price vs 200-day SMA	0.07%
RSI	51.78
RSI Monthly	52.89
RSI Weekly	49.23
Sharpe ratio	1.07x
Sortino ratio	1.83
Total Return	3.16%
Tr YTD	5.98
Tr1m	-0.84%
Tr1w	2.23%
Tr3m	-4.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 311.3M
Operating Income Growth	11.21
Operating Income Growth Q	8.99
Operating Income Growth3 Y	12.47
Operating Income Growth5 Y	6.05
Operating margin	18.98

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	142,675,962%
Net Borrowing	75,072,665
Shares Insiders	0.1%
Shares Institutions	12.03%
Shares Out	291,871,418
Shares Qo Q	-1.49%
Shares Yo Y	-0.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 159.4M
Average Volume	6,432,581.6x
Bv Per Share	6.39
CAPEX	CNY -224.1M
Ch10y	-35.59
Ch1m	-0.84
Ch1w	2.23
Ch1y	20.85
Ch3m	-4.95
Ch3y	-22.66
Ch5y	5.42
Ch6m	-0.98
Change	1.43%
Change From Open	0.92
Close	14
Days Gap	0.5
Depreciation Amortization	85,774,704
Dollar Volume	82,689,369
Earnings Date	2026-04-23
EBIT	CNY 311.3M
EBITDA	CNY 397.1M
EPS	CNY 0.27
F Score	7
FCF	CNY 159.4M
FCF EV Yield	3.74x
FCF Per Share	CNY 0.55
Financing CF	-196,760,286
Fiscal Year End	December
Founded	1,998
Goodwill	145,579,762
Graham Number	6.17725
Graham Upside	-56.5
Income Tax	CNY 43.3M
Investing CF	-256,257,335
Is Primary Listing	1
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	2020-05-25
Last Split Type	Forward
Lynch Fair Value	CNY 1.33
Lynch Upside	-90.65
Ma150	14.18
Ma150ch	0.18%
Ma20	13.86
Ma20ch	2.43%
Net CF	-73,939,205
Next Earnings Date	2026-07-24
Open	14.07
P FCF Ratio	25.99
P OCF Ratio	10.81
Payment Date	2026-01-08
Position In Range	77.27
Ppne	785,812,739
Price Date	2026-05-08
Price EBITDA	CNY 10.44
Ptbv Ratio	2.75
Relative Volume	0.92x
Revenue	1,639,998,414x
Tax By Revenue	2.64x
Tax Rate	32.85%
Tr6m	0.44%
Volume	5,823,195

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/603309 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.8%

$0.40 annual per share

Payout ratio

+280.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+28.5%

0 consecutive years of growth

Total shareholder yield

+3.2%

Next ex-dividend date: 2026-01-08

Performance

SHA/603309 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/603309?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.3%

Negative means the company is buying back shares.

Technical

SHA/603309 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.8

Neutral momentum band

Price vs 200-day MA

+0.1%

50/200-day relationship not available

Beta (5Y)

-0.17

Less volatile than the market

Sharpe ratio

1.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/603309

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/603309 stock rating?

sha/603309 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/603309 analysis?

The full report lives at /stocks/sha/603309/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/603309?

The latest report frames sha/603309 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/603309 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.